Biosynex – Risankizumab

i-Tracker Risankizumab (Biosynex) is an automated assay intended for the quantitative measurement of Risankizumab (anti-IL23 agent) in human serum or plasma samples.

Biosynex – i-Tracker: High-performance TDM assays for biologics

Therapeutic Drug Monitoring (TDM) of biologics entails measuring drug and anti-drug antibody concentrations, with subsequent possible dose adjustment to ensure optimised dosing for the patient.

IMMUNO-TROL FEIA – A complete range of Quality Controls for your Phadia system

Products are for professional/laboratory use only. Explore the new range of Theradiag IMMUNO-TROL FEIA – a complete range of third-party Quality Controls specifically designed for use with Phadia EliA assays. IMMUNO-TROL FEIA is suitable for use on the Thermo Fisher Phadia range of systems – Phadia 250, Phadia 2500E/EE, Phadia 200.

Fast and innovative CLIA automation for the monitoring of patients treated with Infliximab

Products are for professional/laboratory use only. Abacus dx are pleased to present this poster from Theradiag on the performance of the new and innovative i-Tracker infliximab and anti-infliximab assays for use in Therapeutic Drug Monitoring (TDM)

The revolution is here! Theradiag i-Tracker for Therapeutic Drug Monitoring

Products are for professional/laboratory use only. Abacus dx is pleased to launch Theradiag i-Tracker on the IDS iSYS – the first fully automated, random-access platform for Therapeutic Drug Monitoring (TDM).

Abacus dx Publication of the month

Products are for professional/laboratory use only. Swapping versus dose optimization in patients losing response to adalimumab with adequate drug levels. Roblin X, Genin C, Nancey S, Williet N, Veyrard P, Boschetti G, Phelip JM, Berger AE, Killian M, Waeckel L, Flourie B and Paul S. Inflammatory Bowel Diseases, 2021, Aug 18:izab158.